Literature DB >> 881822

Use of performance-intensity functions for diagnosis.

D D Dirks, C Kamm, D Bower, A Betsworth.   

Abstract

Performance-intensity (PI) functions for phonetically balanced (PB) word lists were obtained for a group of normal listeners (27 ears), and for two groups of patients with cochlear (89 ears) and retrocochlear disorders (eight ears). Listeners with normal hearing or cochlear disorders exhibited mild to moderate reductions in discrimination score as the speech level was raised above the PB maximum. In contrast, patients with retrocochlear disorders showed a pronounced rollover phenomenon, characterized by a rapid decline in performance as the speech level was raised above the maximum discrimination score.

Entities:  

Mesh:

Year:  1977        PMID: 881822     DOI: 10.1044/jshd.4203.408

Source DB:  PubMed          Journal:  J Speech Hear Disord        ISSN: 0022-4677


  5 in total

1.  Introduction to the Audiological Evaluation: Case-Based Applications to Patients with Skull Base Disease.

Authors:  Kelsey A Dumanch; Gayla L Poling
Journal:  J Neurol Surg B Skull Base       Date:  2019-02-04

2.  Level-dependent changes in perception of speech envelope cues.

Authors:  Judy R Dubno; Jayne B Ahlstrom; Xin Wang; Amy R Horwitz
Journal:  J Assoc Res Otolaryngol       Date:  2012-08-08

3.  Brainstem auditory-evoked responses and clinical picture in a one year follow-up of 18 patients with Friedreich ataxia.

Authors:  G Finocchiaro; A Formenti; F Baiocco; S Di Donato
Journal:  Ital J Neurol Sci       Date:  1985-03

4.  Hidden Hearing Loss? No Effect of Common Recreational Noise Exposure on Cochlear Nerve Response Amplitude in Humans.

Authors:  Sarah K Grinn; Kathryn B Wiseman; Jason A Baker; Colleen G Le Prell
Journal:  Front Neurosci       Date:  2017-09-01       Impact factor: 4.677

5.  A Comparison of Environment Classification Among Premium Hearing Instruments.

Authors:  Anusha Yellamsetty; Erol J Ozmeral; Robert A Budinsky; David A Eddins
Journal:  Trends Hear       Date:  2021 Jan-Dec       Impact factor: 3.293

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.